MeSH 搜索器

PCSK9 Inhibitors

Agents that inhibit Proprotein Convertase Subtilisin/Kexin Type 9 (see PROPROTEIN CONVERTASE 9 (PCSK9)), an enzyme that plays an important role in the degradation of the LDL receptors. It favors LDL catabolism and reduces plasma LDL-cholesterol (LDL_C) level.
推出的年份: 2022
副标题
树号: D27.505.519.186.071.202.685, D27.505.519.389.745.800.506, D27.505.954.557.500.202.685
MeSH 单一 ID: D000091362
进入的组:
  • PCSK9 Inhibitors, Cardiovascular
  • Cardiovascular PCSK9 Inhibitors
  • Inhibitors, Cardiovascular PCSK9
  • PCSK9 Inhibitors Cardiovascular
  • Cardiovascular, PCSK9 Inhibitors
早前的内容:
  • Anticholesteremic Agents (2018-2021)

留言 (0)

沒有登入
gif